Dow Jones Top Company Headlines at 1 PM ET: Intel Shares Slide as Costs Pile Up in Bid to Meet AI Demand | Two ...
Intel Shares Slide as Costs Pile Up in Bid to Meet AI Demand
The troubled chip maker has seen its shares rise with AI demand and new investors, but revenue sagged 3.9% year-over-year to $13.7 billion.
----
Two European Companies-With a Big Unpaid Bill-Want to Help Rebuild Venezuela's Economy
Italy's Eni and Spain's Repsol are seeking repayment for gas they have been pumping into the country free of charge.
----
TikTok Finalizes Deal to Keep Operating in the U.S.
The agreement was negotiated to comply with a 2024 law requiring the company to make a deal to address U.S. national-security concerns.
----
SLB Eyes More International Activity as It Moves Past Challenging 2025
SLB logged higher fourth-quarter revenue and said some of the challenges it faced last year are behind it, as it stands to benefit from increasing international activity.
----
Booz Allen Boosts Profit Outlook as Cost Cuts Take Hold
Booz Allen Hamilton raised its profit outlook for the fiscal year as its cost-saving efforts, prompted by the Trump administration's cuts to government-contract funding for consultants, began to boost its bottom line.
----
Ericsson Shares Jump on Earnings Beat and Cash Returns
Shares rose as much as 12% in early European trades as the company returns cash to shareholders following cost-cutting measures and the sale of its Iconectiv business.
----
BASF Earnings Miss Guidance
Shares fell after the chemical group prereleased earnings that fell short of both its guidance and consensus expectations.
----
Exxon-Backed Coalition Challenges How Companies Account for Emissions. Some Say It Could Stop Them From Decarbonizing.
Leading climate figures argue the "E-ledgers" approach absolves businesses of their climate responsibilities.
----
Arms Maker CSG's Shares Surge on Amsterdam Stock-Market Debut
The stock was 28% higher than its initial asking price-implying a market value of more than $37 billion-making it the world's largest defense IPO ever.
----
Sanofi Says Its Amlitelimab Drug Showed Promising Results in Treating Eczema
Sanofi said its amlitelimab drug confirmed its potential to treat eczema in patients 12 years and older in two late-phase studies.
----
Babcock Picks Internal Successor as CEO Lockwood Plans to Retire
Harry Holt will be promoted to chief executive officer when David Lockwood retires after roughly half a decade at the helm.
----
Airlines Brace for Weekend of Travel Chaos as Winter Storm Fern Barrels Across U.S.
Airlines have already canceled nearly 70 flights, but that number is likely to increase. Weathertrends360 says the storm is likely to hurt retail store traffic on the last weekend of their fiscal fourth quarters.
----
First Brands Lenders Balk at Second Lifeline, Explore Liquidation
Top lenders to the auto-parts supplier are resisting a second loan sought by the company after the original bankruptcy financing collapsed in value.
(END) Dow Jones Newswires
January 23, 2026 13:15 ET (18:15 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for November
This Once-Hot AI Stock Now Looks Deeply Undervalued
The 10 Best Companies to Invest in Now
He Tried Shorting Jim Cramer’s Stock Picks. It Cost Him More Than Money
